The present invention relates to a novel pharmaceutical combination for the treatment of infectious diseases caused by intracellular pathogens, particularly malaria. Specifically, the present invention relates to a novel pharmaceutical combination comprising drugs having intra-erythrocytic effect on pathogen along w...

The present invention relates to a novel pharmaceutical kit for producing an immune response against infectious diseases caused by intracellular pathogens, particularly malaria. Specifically, the present invention relates to a novel pharmaceutical kit comprising atleast one unit dosage of pathogenic inoculum and atl...

The present disclosure provides an enoxaparin-based composition useful as a blood-stage malaria immunotolerance suppressing formulation. More particularly, the present disclosure provides a composition comprising Plasmodium antigen expressing cells that have been exposed to Enoxaparin and an immunologically acceptab...